Clive Zent

20PUBLICATIONS
73CO-AUTHORS
Haematological tumoursHaematologyMolecular targetsCardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 09, 2026
Efficacy of high-frequency low-dose rituximab and acalabrutinib in chronic lymphocytic leukemia.

|Apr 14, 2026
Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

Clive S Zent, Enrico Tiacci, Robert J Kreitman

|Jan 02, 2025
Treatment of Relapsed/Refractory CLL Patients With PI3Kδ Inhibitor and Anti-CD20 Antibody Rapidly Decreases Tumor Burden but Could Induce Resistance.

Jennifer E Bruno, Christine A Herne, Andrea M Baran

|Jun 08, 2024
Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms.

Michael Grever, Leslie Andritsos, Mirela Anghelina

|Oct 23, 2023
Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia.

Brian T Hill, Shuo Ma, Clive S Zent

|Jul 24, 2023
Long-term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial Bruton tyrosine kinase inhibitors therapy for chronic lymphocytic leukemia or lymphoplasmacytic lymphoma.

Michael T Brady, Nathan Laniewski, Myla Strawderman

Pageof 4

Frequent Collaborators

5 joint publications

Sameer A Parikh

5 joint publications

Alessandro Gozzetti

5 joint publications

Paul M Barr

4 joint publications

Pier Luigi Zinzani